CXCL8 and congenital rubella syndrome: Further, we detect the selective upregulation of interleukin-6 (IL-6) and hsa-miR-21, but not interleukin-8 (IL-8) or hsa-miR-16, in the serum of patient with cytokine release syndrome (CRS).